10.67% CAGR growth by 2023 in the Injectable Drug Delivery Technology Market| Key Vendors - BECTON DICKINSON, PFIZER, GERRESHEIMER AG, TERUMO CORPORATION, ELI LILY & COMPANY, among others

Market Analysis:

North America to hold the Largest Share of the Market
North America holds the major share of approximately more than 42 percent in 2017 and is expected to grow in the forecast period due to factors, such as rising incidence of cardiovascular diseases, growing geriatric population, and the strong presence of industry players in that region. Europe has holds the second largest position in the market followed by APAC region.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/17176
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Some of the most common chronic diseases include, heart disease, stroke, type 2 diabetes, obesity, cancer, and arthritis. Cancer and heart diseases together accounted for an approximate of 46 percent of all deaths. It has also reported that about half of the adults in United States had one or more chronic conditions and one if four had more than two chronic conditions. Since, the adoption rate of injectable drug delivery devices is high among the population suffering from diseases, like diabetes and heart related disorders, the increasing prevalence of chronic diseases is expected to contribute for the growth of injectable drug delivery technology market in the forecast period. The convenience in handling syringes and the automation of dispensing the drug in exact proportions is also contributing to the growth of the market.

Request Discount on this report @ https://marketprognosis.com/discount-request/17176
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Market Segments:
Injectable Drug Delivery Technology Market for Therapeutics is segmented by:
1. Type: Devices (Self-Injection Devices, Conventional Injection Devices), Formulation (Conventional Drug Delivery, Novel Drug Delivery) , Others
2. Application: Cardiovascular Disease, Diabetes, Regenerative Medicine, Oncology, Autoimmune Disorders, Hepatitis B, Others
3. Geography: North America, South America, Europe, Asia Pacific, Middle East & Africa

Key Developments in the Market
• April 2017: BD (Becton, Dickinson and Company) and C. R. Bard, Inc. has entered into a definitive agreement.

Enquiry before Buying @ https://marketprognosis.com/enquiry/17176
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today's complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.